UMIN-CTR Clinical Trial

Basic information
Public title	A verification test of blood flow and skin quality effects of head massage treatment.
Acronym	A verification test of blood flow and skin quality effects of head massage treatment.
Scientific Title	A verification test of blood flow and skin quality effects of head massage treatment.
Scientific Title:Acronym	A verification test of blood flow and skin quality effects of head massage treatment.
Region	Japan

Condition
Condition	Healthy adults
Classification by specialty	Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	To verify blood flow and skin qulity effects bring by head massage treatment.
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	*Measuring blood flow of face *Brown stains and/or red parts by shooting face image (front, right and left).
Key secondary outcomes	*Vas questionnaire *Chromogranin A in saliva *Oxytocin *Shape change of face image by visually confirmation

Base
Study type	Interventional

Study design
Basic design	Single arm
Randomization	Non-randomized
Randomization unit
Blinding	Open -no one is blinded
Control	Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	1
Purpose of intervention	Prevention
Type of intervention	Maneuver
Interventions/Control_1	Washing face- measurements, saliva collection and questionnaires- head massage treatment- measurements, saliva collection and questionnaires- resting- measurements, saliva collection and questionnaires
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	60 years-old >
Gender	Female
Key inclusion criteria	1. Female aged over 20 years and less than 60 years when informed consent. 2. Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent prior to the study.
Key exclusion criteria	1. Subjects who have smoking habit. 2. Subjects who are cold-sensitive constitution. (including subjects like that who feel cold on their hands and foots even in summer) 3. Subjects who are receiving medication due to treatment of disease. 4. In a past month, subjects who have had custom of taking or applying medicine for the treatment of diseases. (Except for cold but include for pollen allergy.) 5. Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. 6. Pregnant or expected pregnant, or lactating women. 7. Subjects who have symptom of dermatologic disease such as atopic dermatitis. 8. Subjects who have undergone surgery on investigation objective portion within the past 6 months. 9. Subjects who are participating the other clinical tests. Subjects who participated within a month prior to the current study and/or who plan to participate the other clinical tests. 10. Other who is determined ineligible by investigator.
Target sample size	20

Research contact person
Name of lead principal investigator	1st name Hiromi Middle name Last name Niwa
Organization	Share Company Ltd.
Division name	President
Zip code	135-0063
Address	2107 Galleria Grande, 1-2-11, Ariake, Koto-ku, Tokyo 135-0063, Japan
TEL	090-2324-7550
Email	cpcc-contact@cpcc.co.jp

Public contact
Name of contact person	1st name Yukihiro Middle name Last name Yada
Organization	University of Tsukuba, School of Integrative
Division name	Global Majors
Zip code	305-8577
Address	1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577 Japan
TEL	029-853-7344
Homepage URL
Email	yada.yukihiro.gb@u.tsukuba.ac.jp

Sponsor
Institute	Share Company Ltd.
Institute
Department

Funding Source
Organization	Share Company Ltd.
Organization
Division
Category of Funding Organization	Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor	University of Tsukuba, School of Integrative
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Institutional Review Board of Chiyoda Paramedical Care Clinic
Address	2F Sanwauchikanda Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, Japan
Tel	03-5297-5548
Email	IRB@cpcc.co.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2021 Year 02 Month 22 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Completed
Date of protocol fixation	2020 Year 02 Month 21 Day
Date of IRB	2020 Year 02 Month 21 Day
Anticipated trial start date	2020 Year 02 Month 22 Day
Last follow-up date	2020 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date	2020 Year 02 Month 21 Day
Last modified on	2020 Year 10 Month 09 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045079